Influenza vaccines
AssigneesInvVax, Inc., The Regents of the University of California
InventorsArthur Young, Ren Sun, Nicholas C. Wu
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions related to vaccines, e.g., influenza vaccines, including, peptide based vaccines, nucleic acid based vaccines, recombinant virus based vaccines, antibody based vaccines, and virus based vaccines. Also provided herein are methods related to vaccines, e.g., influenza vaccines, including methods of identifying epitopes for the vaccines, producing, formulating, and administering the vaccines.
Claims20
A non-naturally-occurring polypeptide comprising at least a first epitope, a second epitope, and a third epitope, wherein the first epitope, the second epitope, and the third epitope differ from each other;
- wherein the first epitope, the second epitope, and the third epitope are selected from the group consisting of SEQ ID NOs:
- 40, 58, 61, 43, 51, 93, 22, 49, 82, 88, 34, and a variant of SEQ ID NO:
- 88 that lacks the N-terminus V residue.
A polypeptide, comprising epitopes set forth as SEQ ID NOs:
- 2, 3, 8, 11, 12, 17, 21, 22, 24, 32-34, 40, 41, 43, 49, 51, 58, 59, 61, 62, 70, 73-78, 82, 84-86, 92-94, and a variant of SEQ ID NO:
- 88 that lacks the N-terminus V residue.
Dependencies are inferred from the claim text.